During the past decade, St. Joseph Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph Hospital" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Spectranetics Corporation" with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "HealthCore-NERI" with 1 trials sponsored and "Mercator MedSystems, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph Hospital" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph Hospital" are "Peripheral Arterial Disease" (2 trials), "Peripheral Artery Disease" (2 trials), "Arterial Occlusive Diseases" (1 trials), "Artery Diseases, Peripheral" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "St. Joseph Hospital" in a lesser frequency.

Most popular intervention types in "St. Joseph Hospital" are "Device" (5 trials), "Drug" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cardiovascular Ingenuity (CVI) Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter" (1 trials), "Dexamethasone Sodium Phosphate Injection, USP" (1 trials), "ELUVIA (Stent Implantation)" (1 trials), "EverCross Percutaneous Transluminal Balloon Catheter" (1 trials) and "EverCross™ 0.035 PTA Balloon Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph Hospital" are 7 trials for "All" genders.

Currently, there are NaN active trials in "St. Joseph Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in St. Joseph Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".